CME Group Inc. (NASDAQ:CME) Shares Acquired by Sigma Planning Corp

Posted by Defense World Staff on Apr 5th, 2023

Sigma Planning Corp grew its stake in CME Group Inc. (NASDAQ:CME – Get Rating) by 1.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,323 shares of the financial services provider’s stock after buying an additional 120 shares during the period. Sigma Planning Corp’s holdings in CME Group were worth $1,904,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in shares of CME Group by 1.3% in the 3rd quarter. Vanguard Group Inc. now owns 32,767,510 shares of the financial services provider’s stock valued at $5,804,109,000 after buying an additional 429,912 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in CME Group by 0.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 6,913,562 shares of the financial services provider’s stock worth $1,224,597,000 after purchasing an additional 31,354 shares during the period. Amundi boosted its stake in CME Group by 0.9% during the 2nd quarter. Amundi now owns 2,633,574 shares of the financial services provider’s stock worth $525,475,000 after purchasing an additional 23,261 shares during the period. Legal & General Group Plc boosted its stake in CME Group by 6.9% during the 2nd quarter. Legal & General Group Plc now owns 2,487,644 shares of the financial services provider’s stock worth $509,231,000 after purchasing an additional 159,962 shares during the period. Finally, Sarasin & Partners LLP boosted its stake in CME Group by 9.4% during the 3rd quarter. Sarasin & Partners LLP now owns 1,740,798 shares of the financial services provider’s stock worth $308,348,000 after purchasing an additional 148,854 shares during the period. Institutional investors and hedge funds own 85.09% of the company’s stock.

CME Group Stock Performance

Shares of CME opened at $193.04 on Wednesday. The company has a 50-day simple moving average of $183.40 and a 200-day simple moving average of $177.75. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.13. The company has a market capitalization of $69.44 billion, a PE ratio of 26.12, a P/E/G ratio of 3.72 and a beta of 0.41. CME Group Inc. has a 52-week low of $166.54 and a 52-week high of $247.01.

CME Group (NASDAQ:CME – Get Rating) last announced its quarterly earnings results on Wednesday, February 8th. The financial services provider reported $1.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.02. The business had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. CME Group had a net margin of 53.61% and a return on equity of 10.43%. The business’s revenue was up 5.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.66 EPS. Equities research analysts predict that CME Group Inc. will post 8.43 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 27th. Shareholders of record on Friday, March 10th were issued a dividend of $1.10 per share. This is an increase from CME Group’s previous quarterly dividend of $1.00. This represents a $4.40 annualized dividend and a yield of 2.28%. The ex-dividend date was Thursday, March 9th. CME Group’s dividend payout ratio (DPR) is 59.54%.

Analyst Upgrades and Downgrades

CME has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft increased their price target on shares of CME Group from $200.00 to $218.00 in a research note on Thursday, February 9th. StockNews.com initiated coverage on shares of CME Group in a research note on Thursday, March 16th. They set a “hold” rating for the company. Credit Suisse Group increased their price target on shares of CME Group from $192.00 to $198.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 7th. UBS Group reduced their target price on shares of CME Group from $226.00 to $220.00 in a research note on Thursday, January 5th. Finally, Morgan Stanley raised their target price on shares of CME Group from $196.00 to $201.00 and gave the stock an “equal weight” rating in a research note on Monday, February 13th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $219.83.

CME Group Company Profile

(Get Rating)

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.